Oramed to Host Key Opinion Leader Webinar on Need for Oral Insulin in Type 2 Diabetes
Wednesday, March 30, 2022, at 12:00 p.m. ET NEW YORK , March 22, 2022 /PRNewswire/ – Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that it will host a
